Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-227,248
Closed -$18.8M 574
2022
Q1
$18.8M Sell
227,248
-14,372
-6% -$1.16M 0.17% 148
2021
Q4
$21.1M Sell
241,620
-10,647
-4% -$1,000K 0.18% 139
2021
Q3
$22M Sell
252,267
-34,297
-12% -$3.03M 0.21% 118
2021
Q2
$22.3M Sell
286,564
-153,699
-35% -$12M 0.21% 126
2021
Q1
$30.9M Sell
440,263
-51,868
-11% -$3.36M 0.23% 88
2020
Q4
$31.8M Buy
492,131
+59,650
+14% +$3.55M 0.22% 86
2020
Q3
$25.8M Sell
432,481
-14,704
-3% -$835K 0.18% 115
2020
Q2
$24.7M Sell
447,185
-38,207
-8% -$2.02M 0.2% 117
2020
Q1
$23.5M Sell
485,392
-304,009
-39% -$15.7M 0.22% 107
2019
Q4
$41.8M Buy
789,401
+263,682
+50% +$14.5M 0.29% 66
2019
Q3
$28.9M Sell
525,719
-439,773
-46% -$24.3M 0.18% 137
2019
Q2
$55M Sell
965,492
-79,715
-8% -$4.31M 0.38% 44
2019
Q1
$56.1M Sell
1,045,207
-127,006
-11% -$6.47M 0.41% 37
2018
Q4
$52.9M Sell
1,172,213
-21,217
-2% -$1.02M 0.43% 39
2018
Q3
$61.5M Sell
1,193,430
-147,312
-11% -$7.16M 0.47% 32
2018
Q2
$59.1M Buy
1,340,742
+225,425
+20% +$10.4M 0.41% 36
2018
Q1
$51M Buy
+1,115,317
New +$55.4M 0.32% 54

Other funds holding ORCL

Mackay Shields LLC's ORCL Position: Q2 2022 in Review

Mackay Shields LLC sold out of Oracle (ORCL) in Q2 2022, closing a stake of 227,248 shares — an estimated $18.8M sold.

Mackay Shields LLC first reported a position in ORCL in Q1 2018 and held it in 17 quarters. The position peaked at $61.5M in Q3 2018. 2,191 funds tracked by Wall St. Rank hold ORCL as of Q2 2022.

  • Mackay Shields LLC reported no remaining Oracle position as of Q2 2022 after selling out during the quarter.
  • Mackay Shields LLC sold 227,248 Oracle shares in Q2 2022, an estimated $18.8M.
  • Mackay Shields LLC first reported a position in Oracle in Q1 2018 and held it in 17 quarters.
  • Mackay Shields LLC's Oracle position peaked at $61.5M in Q3 2018.
  • 2,191 funds tracked by Wall St. Rank held Oracle as of Q2 2022.

Based on Mackay Shields LLC's 13F filing for Q2 2022, filed 3 Aug 2022.